Nasal Decongestant PE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Nasal Decongestant PE
Generic name: PHENYLEPHRINE HCL 10 MG
Manufacturer: NUVICARE LLC
Product type: HUMAN OTC DRUG
SPL set ID: 4cde41dd-a0a7-45e7-aff3-ee9402dfdff2
SPL ID: 5869b99d-5cbb-41a1-a32a-82afd167d30e
Version: 2
Effective date: 2025-12-19
Source export date: 2026-11-06
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/10387d7618367cd955339e75d48af3d11f99f789153db05c529d9fad6eccc645/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:15:53

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		Nasal Decongestant PE	openfda.brand_name
generic name		PHENYLEPHRINE HCL 10 MG	openfda.generic_name
manufacturer name		NUVICARE LLC	openfda.manufacturer_name
ndc	package	84324-010-01	openfda.package_ndc
ndc	product	84324-010	openfda.product_ndc
ndc11	package	84324001001	derived:openfda.package_ndc
rxcui		1049182	openfda.rxcui
spl id		5869b99d-5cbb-41a1-a32a-82afd167d30e	id
spl set id		4cde41dd-a0a7-45e7-aff3-ee9402dfdff2	set_id
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. if you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.